在美国,严重不受控制的喘患者中增加的成本负担
Autumn Burnette1, Yan Wang2, Pallavi B Rane2
1Division of Allergy and Immunology, Howard University, Washington, DC.
Journal of managed care & specialty pharmacy
|July 5, 2023
概括
与非严重喘患者相比,患有严重不受控制的喘 (SUA) 的患者承担的医疗费用和工作损失显著更高. 这突显了 SUA 的巨大经济负担,强调了需要有效的管理策略.
科学领域:
- 卫生经济学 卫生经济学
- 肺部病理学 肺部病理学
- 现实世界的证据.
背景情况:
- 严重喘和严重失控喘 (SUA) 的经济影响是巨大的.
- 越来越多的治疗选择和指导方针更新需要对医疗保健资源利用率 (HCRU) 和成本进行当前评估.
- 了解经济负担对于资源分配和患者管理至关重要.
研究的目的:
- 量化和比较全因和喘相关的HCRU和美国SUA患者的成本与非严重喘患者的成本.
- 分析这些患者群体中与缺勤和短期残疾 (STD) 相关的失业和间接成本.
主要方法:
- 美国MarketScan行政索赔数据 (2013-2019) 对患有持续性喘的成年人的回顾性分析.
- 根据全球喘倡议 (GINA) 标准定义的喘严重程度;通过住院或多次门诊/ED访问和类固醇爆发来定义的SUA.
- 在12个月后的指数期内比较HCRU,成本 (直接医疗和药房),失业和间接成本.
主要成果:
- 与不严重喘患者 (16,177美元) 相比,患有SUA的患者的平均全因总医疗费用 (23353美元) 显著更高.
- 严重喘患者,尽管占人口的41.9%,占直接喘相关成本的60.5%; SUA患者 (人口的7.4%) 占17.7%.
- 与不严重的喘患者相比,患有SUA患者的失业时间 (259.3小时) 和性病日数 (7.8) 更大,相关间接成本更高.
结论:
- 患有严重失控喘的患者面临着更高的经济负担.
- 喘患者对与喘相关的整体医疗保健费用做出了不成比例的贡献.
- 这些发现强调了不受控制的严重喘对个人和医疗保健系统的经济影响.
更多相关视频
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
748
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
40.8K
相关概念视频
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.2K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.2K
Inhaled Medications
319
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
319
Asthma: Pathogenesis and Management
452
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
452
COPD: Management Using Bronchodilators and Corticosteroids
250
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
250
